Atlas Trials

Melatonin for Prevention of Metabolic Side Effects of Olanzapine

Clinical trial NCT01593774 · COMPLETED

Trial details

NCT number
NCT01593774
Sponsor
Guilan University of Medical Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Start date
2012-05-01
Primary completion
2013-03-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.